Unbiased Analysis of Today's Healthcare Issues

Thoughts on IOM’s ‘Delivering High-Quality Cancer Care’ Report

The Institute of Medicine (IOM) makes a number of recommendations on how to improve cancer care in their 2013 report.  I have listed them all here.  For some of these recommendations, I have comments below. The Centers for Medicare & Medicaid Services and other payers should design, implement, and evaluate innovative payment models that incentivize […]

Read the rest of this entry »

Access to Oncology Care

Oftentimes, health services research measure access as the distance between a patient and the nearest provider of a given type (e.g., hospital, physician).  This issue of access is particularly relevant for individuals with cancer, since cancer care typically requires supervisions from specialist oncologists.  In most cases, health services researchers assume that individuals located far from […]

Read the rest of this entry »

Cost of Cancer in Europe

In 2008, 2.45 million people were diagnosed with cancer and 1.23 million died because of cancer in the European Union (EU). What is the economic burden of cancer?  A paper by Luengo-Fernandez (2013) aims to estimate just this quantity.  They find that: Cancer cost the EU €126 billion in 2009…Across the EU, the health-care costs […]

Read the rest of this entry »

Cancer screening rates

The National Cancer Institute (NCI) publishes screeening rates for breast, cervical, and colorectal cancers over the past 25 years.  I have reproduced the charts below.  I wonder how the USPSTF recommendation in November 2009 that women ages 40 to 49 should not undergo screening unless they are in a high-risk group will affect mammography rates in the most recent […]

Read the rest of this entry »

Cancer Incidence and Deaths in Europe

Which cancers have the highest incidence rates in Europe?  Which ones cause the most deaths?  According to an article by Karim-Kos et al. (2008), here is the answer:

Read the rest of this entry »

Reducing Cancer Treatment Costs

Cancer is the second leading cause of death in the United States. Reducing mortality and morbidity from many types of cancer would be an enormous breakthrough. Although the benefits from high-quality cancer care are clear, cancer care is expensive. GoozNews reports that a UnitedHealthcare official stated that reimbursement for cancer care now accounts for 12 […]

Read the rest of this entry »

Variation in End-of-Life Cancer Treatments

According to a recent Dartmouth Atlas study: “The nation’s most elite cancer care centers performed only modestly better than community hospitals at meeting recognized quality standards for treating dying cancer patients, displaying similar patterns of relatively aggressive, high-intensity treatments in the final weeks of these patients’ lives… The Dartmouth researchers also found that even among […]

Read the rest of this entry »

Fraudulent Cancer Research: An Exception or the Tip of the Iceberg

Yesterday, 60 Minutes reported on Dr. Anil Potti, researcher at Duke University.  Dr. Potti supposedly offered cancer patients improved cancer treatments.  These recommendations, however, were based on falsified data. “Five years ago, Duke University announced it had found the holy grail of cancer research. They’d discovered how to match a patient’s tumor to the best chemotherapy […]

Read the rest of this entry »

California Health Care Almanac

The California Health Care Foundation (CHCF)’s Health Care Almanac provides some unique insights on trends in health care quality in California and for the United States as a whole.  Many of the national figures for the Almanac come from the CDC (BRFSS and Vital Stats) and AHRQ’s National Healthcare Quality Report.  California quality figures come […]

Read the rest of this entry »

Does getting cancer incentivize individuals to switch from Medicare managed care to FFS?

Medicare beneficiaries have a choice: pick the standard Medicare fee-for-service (FFS) benefit or rely on managed care plans to supply their healthcare through the Medicare Advantage (MA) program.  Many Medicare beneficiaries prefer MA because it offers them lower out-of-pocket costs and provide benefits not available in the traditional FFS Medicare program. Other beneficiaries prefer the […]

Read the rest of this entry »